These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4785234)

  • 1. The estimation of relative potency from two parabolas in symmetric bioassays.
    Williams DA
    Biometrics; 1973 Dec; 29(4):695-700. PubMed ID: 4785234
    [No Abstract]   [Full Text] [Related]  

  • 2. On biological assays involving quantal responses.
    Waud DR
    J Pharmacol Exp Ther; 1972 Dec; 183(3):577-607. PubMed ID: 4636393
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of the biometrician in dosage finding].
    Schneider B
    Arzneimittelforschung; 1977 Feb; 27(2A):257-64. PubMed ID: 577172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-parametric interval estimation of relative potency for dilution assays, including the case of non-monotone dosage response curves.
    Mantel N; Schneiderman MA
    Biometrics; 1975 Sep; 31(3):619-32. PubMed ID: 1174621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated-measures bioassay with correlated errors and heterogeneous variances: a Monte Carlo study.
    Elashoff JD
    Biometrics; 1981 Sep; 37(3):475-82. PubMed ID: 7317557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitting a general sigmoid model to pharmacological response curves [proceedings].
    Davey A; Marriott A; Stockham MA
    Br J Pharmacol; 1976 Oct; 58(2):289P-290P. PubMed ID: 974407
    [No Abstract]   [Full Text] [Related]  

  • 7. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC; Cross JT
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract]   [Full Text] [Related]  

  • 8. [Shelf-life estimation of pharmaceutical products by matrixing].
    Yoshioka S; Aso Y; Kojima S
    Eisei Shikenjo Hokoku; 1996; (114):143-4. PubMed ID: 9037887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of optimal dose.
    Khan MK; Khan MA
    Comput Biomed Res; 1985 Apr; 18(2):193-203. PubMed ID: 3987233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical methodologies of dose-response relationship in epidemiology.
    Park CB
    J UOEH; 1983 Mar; 5 Suppl():175-82. PubMed ID: 6679668
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function.
    Spruill WJ; Wade WE; Cobb HH
    Clin Pharmacol Ther; 2009 Nov; 86(5):468-70. PubMed ID: 19844221
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimating relative potency using prior information.
    Kim PT; Carter EM; Hubert JJ
    Biometrics; 1991 Mar; 47(1):295-301. PubMed ID: 2049503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate bioassay.
    Vølund A
    Biometrics; 1980 Jun; 36(2):225-36. PubMed ID: 6996751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate bioassay, combination of bioassays, and Fieller's theorem.
    Srivastava MS
    Biometrics; 1986 Mar; 42(1):131-41. PubMed ID: 3719050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MASCA-model of the biochemical-pharmacological drug research. Part 3: Structure-activity relationships and KANORA (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Sep; 25(9):1355-6. PubMed ID: 1242657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exact confidence region for a relative potency estimated from combined bioassays.
    Williams DA
    Biometrics; 1978 Dec; 34(4):659-61. PubMed ID: 749948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Logarithmic dose transformation in epidemiologic dose-response analysis: use with caution.
    Ginevan ME; Watkins DK
    Regul Toxicol Pharmacol; 2010 Nov; 58(2):336-40. PubMed ID: 20655968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A characterization on misspecification in the general linear regression model.
    Rosenberg SH; Levy PS
    Biometrics; 1972 Dec; 28(4):1129-33. PubMed ID: 4648794
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of botulinum toxin activity: evaluation of the lethality assay.
    Pearce LB; Borodic GE; First ER; MacCallum RD
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):69-77. PubMed ID: 8079356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.